TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation

This publication has 60 references indexed in Scilit:

• Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1
  Proceedings of the National Academy of Sciences, 2007
• Defects in Yolk Sac Vasculogenesis, Chorioallantoic Fusion, and Embryonic Axis Elongation in Mice with Targeted Disruption of Yap65
  Molecular and Cellular Biology, 2006
• TAZ: A β-Catenin-like Molecule that Regulates Mesenchymal Stem Cell Differentiation
  Cell Cycle, 2005
• The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis
  Nature Cell Biology, 2005
• A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt–Oram syndrome
  Proceedings of the National Academy of Sciences, 2005
• TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation
  Science, 2005
• Transcriptional Coactivation of Bone-Specific Transcription Factor Cbfa1 by TAZ
  Molecular and Cellular Biology, 2003
• Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
  2001
• TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
  Genes & Development, 2001
• TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins
  The EMBO Journal, 2000